ClinicalTrials.govpublic full text
Comparative Effectiveness of Tirzepatide Versus Sitagliptin in Individuals at Cardiovascular Risk (TIRZSITA-CVOT)
type2 diabetes mellitus, atherosclerotic cardiovascular disease
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 126025
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.